AMC Bio’s scalable platform technology enables commercialization of truncated, optimized microbial peptide drugs for more sustainable anticancer, antiviral, and antibiotic therapies.
Key Takeaways
• AMC Bio is developing novel microbial peptide therapeutics with programs at early and late preclinical stages.
• Just as antibiotic discovery from soil microbes revolutionized treatment of bacterial infections in the 20th Century, microbial peptides offer safer and more effective therapeutics for the 21st Century.
• AMC Bio’s highly effective, non-toxic small-molecule therapeutics target solid cancer tumors, viral and bacterial infections.
Company Details
- Employees
- 2
- Founded
- -
- Address
- 91 Route De Romains, Strasbourg,le Grand Est 67200,france
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- http://amc-bio.com
- HQ
- Strasbourg, Le Grand Est
Amc Bio Questions
Amc Bio's website is http://amc-bio.com
Amc Bio's LinkedIn profile is https://fr.linkedin.com/company/amc-bio
Amc Bio has
2 employees.
View email and phone details for 2
employees at Amc Bio.
Amc Bio's industry is
Biotechnology Research
Amc Bio's top competitors are
Moringa Acquisition Corp,
Innology,
Laboratoire Pharmastra,
Think Health Communications,
Coly Biosystems,
Proteogenix,
Daisogel,
Lamina Therapeutics,
Syndivia,
Selecta Biotech.
Amc Bio's categories are Biotechnology Research
Amc Bio's founding year is 2024
